Back to REGN Stock Lookup

REGN Related Analyst Ratings

Jun 18, 2013 07:11 AM Elan Corp (ELN) Could Be Worth $19 in a Takeout - Jefferies

May 17, 2013 06:46 AM UBS Starts Regeneron Pharma (REGN) at Neutral

May 3, 2013 02:41 PM Brean Capital Upgrades Regeneron Pharma (REGN) to Buy, PT $315

May 2, 2013 07:23 AM JMP Securities Upgrades Regeneron Pharma (REGN) to Market Outperform

May 1, 2013 12:55 PM Reduced Competition Adds $35 to Regeneron (REGN) DCF, Deutsche Bank Raises PT to $310

Apr 9, 2013 08:58 AM Goldman Sachs Raises Price Target on Regeneron (REGN) to $215

Apr 3, 2013 09:59 AM Dupilumab Could End of Being 'Blockbuster' Asthma Drug - Analyst (SNY) (REGN)

Mar 28, 2013 06:52 AM JMP Securities Starts Regeneron Pharma (REGN) at Market Perform

Feb 28, 2013 06:53 AM Barclays Starts Regeneron Pharma (REGN) at Overweight

Jan 17, 2013 08:23 AM Brean Capital Downgrades Regeneron Pharma (REGN) to Hold

Jan 15, 2013 02:23 PM Baird Releases Bullish Note on Regeneron (REGN), Eylea Taking Share

Jan 15, 2013 07:12 AM Jefferies Downgrades Regeneron Pharma (REGN) to Hold, Sees Limited Eylea Upside

Nov 20, 2012 10:07 AM Regeneron (REGN) Pops Higher; Deutsche Sees AAO/ASRS as Positive for Branded Drugs

Nov 13, 2012 06:54 AM Credit Suisse Starts Regeneron Pharma (REGN) at Outperform

Nov 7, 2012 10:09 AM RBC Thinks Amgen's (AMGN) AMG145 Has 'Compelling' Safety Profile Profile; Sees $10B Market Opportunity

Oct 22, 2012 02:26 PM Leerink Swann Raises Price Target on Regeneron (REGN) to $182

Oct 18, 2012 10:51 AM Regeneron (REGN) May See Pressure in U.S. Over Zaltrap Pricing (SNY)

Oct 16, 2012 03:38 PM Regeneron (REGN) Could Benefit as Avastin Suffers as Result of Meningitis Outbreak

Oct 4, 2012 12:54 PM Baird Boosts Price Target on Regeneron (REGN) as Survey Indicates Positive Eylea Momentum

Aug 7, 2012 07:50 AM Lazard Capital Starts Regeneron Pharma (REGN) at Neutral

Jul 25, 2012 12:27 PM BMO Capital Upgrades Regeneron Pharma (REGN) to Outperform

Jul 25, 2012 11:09 AM Deutsche Bank Reiterates Bullish Stance on Regeneron (REGN)

Jun 13, 2012 11:35 AM Deutsche Bank Says Fovista Will Be Complement to Regeneron's (REGN) Eylea, Not Competitor

Jun 1, 2012 12:04 PM Regeneron (REGN) Shares Punished as Analyst Warns on Eylea Growth

May 9, 2012 11:59 AM Jefferies Trims Target on Regeneron Pharma (REGN) After Arcalyst News, Keeps Buy Rating

Apr 27, 2012 08:42 AM Jefferies Lifts Numbers on Regeneron Pharma (REGN)

Apr 27, 2012 07:55 AM BMO Capital Downgrades Regeneron Pharma (REGN) to Market Perform

Apr 25, 2012 11:05 AM Baird Maintains an 'Outperform' on Regeneron Pharma (REGN); Still Taking Share AND Growing the Branded Market

Apr 12, 2012 10:14 AM Declining Lucentis Market Share Bodes Well for Regeneron's (REGN) Eylea -BMO

Apr 2, 2012 06:45 AM Goldman Sachs Starts Regeneron Pharma (REGN) at Buy, Sees 23% Upside

Mar 29, 2012 03:24 PM Baird Reiterates a 'Outperform' on Regeneron Pharma (REGN); Bullish Thesis Intact

Mar 27, 2012 08:26 AM Baird Sees More Upside on Regeneron Pharma (REGN), Lifts Price Target

Mar 21, 2012 10:49 AM Baird Reiterates an 'Outperform' on Regeneron Pharma (REGN); View ACC As Coming Out Party

Mar 12, 2012 08:24 AM BofA/Merrill Lynch added Regeneron Pharmaceuticals (REGN) to its U.S. 1 List

Mar 9, 2012 08:13 AM Jefferies Sees More Upside for Regeneron Pharma (REGN)

Mar 5, 2012 08:05 AM Leerink Swann Reiterates an 'Outperform' on Regeneron Pharma (REGN); Survey Says: Solid Eylea Outlook in U.S.

Feb 15, 2012 10:44 AM Deutsche Bank Reiterates a 'Buy' on Regeneron Pharma (REGN); Fake Avastin - Our Take on Read Across to REGN's Eylea

Feb 14, 2012 08:13 AM Jefferies Boosts Numbers On Regeneron (REGN) After Strong Q4, Outlook

Feb 13, 2012 04:12 PM Baird Reiterates an 'Outperform' on Regeneron Pharma (REGN); EYLEA Train Keeps On Rollin'....Raising Numbers Again

Feb 7, 2012 07:32 AM Baird Reiterates an 'Outperform' on Regeneron Pharma (REGN); Think This Stock Still Has Legs

Feb 6, 2012 03:27 PM Citi Maintains a 'Neutral' on Regeneron Pharma (REGN); Doctors Consider Eylea as Replacement for Roche's Lucentis

Feb 6, 2012 08:35 AM Piper Jaffray Downgrades Regeneron (REGN) to Neutral

Feb 6, 2012 07:36 AM Jefferies Raises Price Target On Regeneron Pharma (REGN) to $111

Feb 3, 2012 07:51 AM ThinkEquity Starts Regeneron Pharma (REGN) at Buy, Sets $120 Price Target

Jan 30, 2012 08:09 AM BofA/Merrill Lynch Upgrades Regeneron Pharma (REGN) to Buy

Jan 17, 2012 07:57 AM Roth Capital Downgrades Regeneron Pharma (REGN) to Neutral

Jan 10, 2012 12:08 PM Leerink Swann reiterates an 'Outperform' on Regeneron Pharma (REGN); Eylea Posts an Eye-Popping 1st Quarter of Launch

Jan 10, 2012 12:03 PM Brean Murray Carret & Co. maintains a 'Buy' on Regeneron Pharma (REGN); Adjusting Eylea Sales Upward

Jan 10, 2012 11:57 AM Deutsche Bank Raises Price Target on Regeneron Pharma (REGN); First Glimpse at Execution Ability

Jan 10, 2012 07:16 AM Baird Upgrades Regeneron Pharma (REGN) to Outperform, Sees Continued Upside On Strong Eylea Uptake

Back to REGN Stock Lookup